NCT03999658 2023-05-01A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory MalignanciesSorrento Therapeutics, Inc.Phase 2 Withdrawn
NCT03027284 2020-05-19A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerEli Lilly and CompanyPhase 1 Completed19 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts